The PRESERVE-EF (Risk Stratification in Patients With Preserved Ejection Fraction) study evaluated a protocol for identifying patients with ejection fraction ≥40% post-myocardial infarction who might benefit from implantable cardioverter-defibrillator due to a high risk of sudden cardiac death.

Read the Journal Scan